Events, Devices & Diagnostics, Pharma, Startups, Diagnostics

Here are the winners from 2019’s MedCity INVEST Pitch Perfect Contest

This year’s edition of the Pitch Perfect competition involved dozens of live pitches at the MedCity News INVEST conference in Chicago. Here are the startups who came out on top.

MedCity News and Mid-America Healthcare Investors Network hosted the sixth edition of the Pitch Perfect Contest at the annual INVEST conference in Chicago on April 23-24. This year’s competition was especially fierce, with companies moving through a stringent application process for the chance to pitch live during the event and get some face time with some of the top investors in the country.

The 42 finalist companies competed across five tracks: Diagnostics, Health IT, Health Services, Biopharma and Medical Devices.

presented by

Congratulations to the following winners of the MedCity Pitch Perfect contest.

Diagnostics: Odin Technologies 

From left: MedCity News Editor in Chief Arundhati Parmar, Odin Technologies CEO Steven Hansen and MHIN President Dennis Depenbusch

Odin Technologies is a Chicago-based startup that is developing a non-invasive tool for diagnosing and monitoring compartment syndrome in trauma patients. The company’s Valkyrie diagnostic offers a simple way to detect and track tissue perfusion and avoid unnecessary fasciotomies.


Medical Devices: CorInnova 

From left: MedCity News Editor in Chief Arundhati Parmar, CorInnova CEO William Altman and MHIN President Dennis Depenbusch

Houston-based CorInnova has developed a soft, robotic, bi-ventricular cardiac-assist device to give short-term cardiac assistance to patients with heart failure. It is designed to eliminate blood contacting adverse events associated with existing cardiac assist devices and promote heart recovery.


BioPharma: Enzyme by Design

From left: MedCity News Editor in Chief Arundhati Parmar, Enzyme by Design CEO Arnon Lavie and MHIN President Dennis Depenbusch

Enzyme by Design is a pre-clinical stage company with a humanized enzyme therapy for treatment of the orphan disease adult acute lymphoblastic leukemia. With its lead biologic, EbD-1117, the Chicago-based company hopes to help patients achieve cancer remission without the toxic side effects of current therapies.


Health IT: NeuroFlow

From left: MedCity News Editor in Chief Arundhati Parmar, NeuroFlow CEO Christopher Molaro and MHIN President Dennis Depenbusch

Philadelphia-based NeuroFlow is a healthcare technology and analytics company enabling behavioral health access and engagement across the continuum of care. The company combines validated techniques, data science, and behavioral economics to support patients in their daily lives and help providers manage and engage their population.


Health Services: Optonome

From left: MedCity News Editor in Chief Arundhati Parmar, Optonome CEO Dennis Dicker and MHIN President Dennis Depenbusch

Philadelphia-based Optonome allows providers to start and manage their own home health agencies through its technology platform, which combines communication, training and management features to ease the significant administrative burden and make it possible for clinicians to become entrepreneurs.

Picture: Getty Images, Oat_Phawat